Top Markets
#1 Akedo Akedo +54.06%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.26%
#4 Cross Cross +47.18%
#5 Black Phoenix Black Phoenix +34.15%
#6 Velvet Velvet +31.77%
#7 OVERTAKE OVERTAKE +18.70%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.05%
#9 Movement Movement +13.43%
#10 Perle Perle +11.98%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rang in Aktien #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Aktienkurs
$0.02243487
Zuletzt synchronisiert: 2025-06-04
Marktkapitalisierung
$650.09K
Veränderung (1 Tag)
0.39%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Lipidor AB (publ) (LIPI)

Kategorie

Healthcare
EPS für Lipidor AB (publ) (LIPI)
EPS zum December 2024 TTM: $-0.01
Laut den aktuellen Finanzberichten und dem Aktienkurs von Lipidor AB (publ) beträgt das aktuelle EPS des Unternehmens (TTM) $-0.01. Am Ende des Jahres 2023 betrug das EPS $-0.04 ein Rückgang im Vergleich zu dem EPS von 2022, das $-0.14 betrug.
EPS-Verlauf von Lipidor AB (publ) von 2016 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.01 -92.68%
2024 0.00 -92.68%
2023 $-0.04 -70.93%
2022 $-0.14 66.50%
2021 $-0.08 2.38%
2020 $-0.08 9.75%
2019 $-0.07 54.89%
2018 $-0.05 125.96%
2017 $-0.02 -29.97%
2016 $-0.03 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -328,121.98%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -95,154.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -39,110.99%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -224,154.95%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -13,946.15%
US